HOME >> MEDICINE >> NEWS
Bone Marrow With Organ Transplants Reduces Rejection Of Transplanted Organs, Reports University Of Pittsburgh

Results of clinical study presented at Experimental Biology '99 meeting

WASHINGTON, D.C., April 21 -- Organ rejection occurs less often and is less severe in patients who receive infusions of bone marrow from the same donor, researchers from the University of Pittsburgh's Thomas E. Starzl Transplantation Institute report today at Experimental Biology '99. Their findings, which represent six years of study of patients who received the extra boost of donor immune system cells, indicate the procedure is safe and augments the cellular environment that the research team believes is necessary for long-term acceptance of a transplanted organ.

Results of the study--the largest of its kind--are particularly encouraging for the recipients of hearts, lungs and combined kidney and pancreas, reports Abdul Rao, M.D., D.Phil., assistant professor of surgery and pathology and director, section of cellular transplantation. In addition, the outcomes for liver transplant patients suggest that some patients can be weaned from the drugs that control organ rejection. The researchers are selecting these patients for a step-wise weaning protocol, which has not yet been initiated.

Controlling rejection is the key to successful organ transplantation. For the most part, surgeons rely on drugs that suppress the patient's immune response as their main line of defense against an immune system attack. But despite newer and better drugs, organ rejection can still occur, even years after transplantation. Even if the drugs effectively control rejection, they can produce serious medical complications and make the patient more susceptible to cancers and infections, some which can be deadly.

"While the ultimate goal in some of the bone marrow patients is to take them off immunosuppressive drugs, we do not want to interfere with the natural peace-keeping process between the recipient and donor immune systems. In other words, the drugs are necessary, at le
'"/>

Contact: Lisa Rossi
rossiL@msx.upmc.edu
412-624-2607
University of Pittsburgh Medical Center
21-Apr-1999


Page: 1 2 3 4

Related medicine news :

1. Marrow injection gets damaged hearts moving
2. Less Toxic Bone Marrow Transplant Technique May Have More Powerful Anti-Cancer Effect
3. Organ Transplants Helped By Donor Bone Marrow, University Of Pittsburgh Researchers Report At National Transplant Meetings
4. Bone Marrow With Heart And Lung Transplants Reduces Rejection Of Transplanted Organs, Reports University Of Pittsburgh
5. Duke Researchers Identify New Pulmonary Syndrome Associated With Bone Marrow Transplantation For Breast Cancer
6. Organizational traits associated with quality patient care are essential to home care nursing
7. Roche pledges continued support for Organ Transplantation Research Foundation
8. Organ-transplant patients at particluar risk from low MMR vaccine uptake
9. Organ transplant recipients face serious kidney-failure risk, study finds
10. Organically grown foods higher in cancer-fighting chemicals than conventionally grown foods
11. National Conference on Organ Donation and Transplantation

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2019)... ... December 05, 2019 , ... Intelligent.com, ... the Top 54 RHIT Degree Programs for 2020. The comprehensive research guide is ... Each program is evaluated based on curriculum quality, graduation rate, reputation, and post-graduate ...
(Date:12/4/2019)... ... December 04, 2019 , ... A November 12 ... cities offer them as public transit options. The article highlighted the life-changing or life-ending ... confined to a bed to a rider fatality after an incident with a vehicle. ...
(Date:12/4/2019)... ... December 04, 2019 , ... ... Insights Awards™, the only national awards dedicated to recognizing excellence in the areas ... awards were presented in nine different categories during the GlobeSt Healthcare Conference today ...
(Date:12/4/2019)... , ... December 04, 2019 , ... ... study of AZD4041 for treating tobacco use and dependence. The study will investigate ... nervous system (CNS) penetrant antagonist of orexin-1 (hypocretin-1) receptors that is being developed ...
(Date:12/2/2019)... ... ... Interim HealthCare Inc. , a national franchisor of home care, hospice ... . Selected for its multi-pronged approach to building a strong workforce, Interim HealthCare’s commitment ... By 2025, the U.S. will need to hire 2.5 million new healthcare workers to ...
Breaking Medicine News(10 mins):
(Date:12/2/2019)... (PRWEB) , ... December 02, 2019 , ... ... owner of A Mission for Michael, an intensive mental health facility, announced it ... to oversee client relations, business development and national advocacy efforts. , "We are ...
(Date:12/2/2019)... ... December 02, 2019 , ... Smile ... dental groups in the United States, today announced the grand opening of another ... , Patients will enjoy convenient hours, a comfortable office and full-service care ...
(Date:12/2/2019)... ... December 02, 2019 , ... Strong public health departments ... learn, and play. Striving to fulfill their crucial mission, more and more health ... by the Public Health Accreditation Board (PHAB). Today, PHAB announced it has awarded ...
Breaking Medicine Technology:
Cached News: